Cargando…
25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor
Autores principales: | Zu, Shulong, Deng, Yong-Qiang, Zhou, Chao, Li, Jie, Li, Lili, Chen, Qi, Li, Xiao-Feng, Zhao, Hui, Gold, Sarah, He, Jun, Li, Xiang, Zhang, Changqing, Yang, Heng, Cheng, Genhong, Qin, Cheng-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431750/ https://www.ncbi.nlm.nih.gov/pubmed/32811977 http://dx.doi.org/10.1038/s41422-020-00398-1 |
Ejemplares similares
-
Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: From Discovery to Clinical Usage
por: Wang, Yaping, et al.
Publicado: (2020) -
Regulating Innate and Adaptive Immunity for Controlling SIV Infection by 25-Hydroxycholesterol
por: Wu, Tongjin, et al.
Publicado: (2018) -
Modulation of Antiviral Immunity and Therapeutic Efficacy by 25-Hydroxycholesterol in Chronically SIV-Infected, ART-Treated Rhesus Macaques
por: Wu, Chunxiu, et al.
Publicado: (2021) -
Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
por: Zu, Shulong, et al.
Publicado: (2021) -
Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
por: Li, Lili, et al.
Publicado: (2022)